BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 20935166)

  • 1. Up-regulation of soluble vascular endothelial growth factor receptor-1 prevents angiogenesis in hypertrophied myocardium.
    Kaza E; Ablasser K; Poutias D; Griffiths ER; Saad FA; Hofstaetter JG; del Nido PJ; Friehs I
    Cardiovasc Res; 2011 Feb; 89(2):410-8. PubMed ID: 20935166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenovirus-mediated gene transfer of placental growth factor to perivascular tissue induces angiogenesis via upregulation of the expression of endogenous vascular endothelial growth factor-A.
    Roy H; Bhardwaj S; Babu M; Jauhiainen S; Herzig KH; Bellu AR; Haisma HJ; Carmeliet P; Alitalo K; Ylä-Herttuala S
    Hum Gene Ther; 2005 Dec; 16(12):1422-8. PubMed ID: 16390273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial hypertrophy overrides the angiogenic response to hypoxia.
    Choi YH; Cowan DB; Nathan M; Poutias D; Stamm C; del Nido PJ; McGowan FX
    PLoS One; 2008; 3(12):e4042. PubMed ID: 19112498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia is responsible for soluble vascular endothelial growth factor receptor-1 (VEGFR-1) but not for soluble endoglin induction in villous trophoblast.
    Munaut C; Lorquet S; Pequeux C; Blacher S; Berndt S; Frankenne F; Foidart JM
    Hum Reprod; 2008 Jun; 23(6):1407-15. PubMed ID: 18413304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular endothelial growth factor prevents apoptosis and preserves contractile function in hypertrophied infant heart.
    Friehs I; Barillas R; Vasilyev NV; Roy N; McGowan FX; del Nido PJ
    Circulation; 2006 Jul; 114(1 Suppl):I290-5. PubMed ID: 16820588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroblastoma progression correlates with downregulation of the lymphangiogenesis inhibitor sVEGFR-2.
    Becker J; Pavlakovic H; Ludewig F; Wilting F; Weich HA; Albuquerque R; Ambati J; Wilting J
    Clin Cancer Res; 2010 Mar; 16(5):1431-41. PubMed ID: 20179233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired angiogenesis after hindlimb ischemia in type 2 diabetes mellitus: differential regulation of vascular endothelial growth factor receptor 1 and soluble vascular endothelial growth factor receptor 1.
    Hazarika S; Dokun AO; Li Y; Popel AS; Kontos CD; Annex BH
    Circ Res; 2007 Oct; 101(9):948-56. PubMed ID: 17823371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiangiogenic effect of soluble vascular endothelial growth factor receptor-1 in placental angiogenesis.
    Ahmad S; Ahmed A
    Endothelium; 2005; 12(1-2):89-95. PubMed ID: 16036320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial Cells Regulate Physiological Cardiomyocyte Growth via VEGFR2-Mediated Paracrine Signaling.
    Kivelä R; Hemanthakumar KA; Vaparanta K; Robciuc M; Izumiya Y; Kidoya H; Takakura N; Peng X; Sawyer DB; Elenius K; Walsh K; Alitalo K
    Circulation; 2019 May; 139(22):2570-2584. PubMed ID: 30922063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between intratumoral free and total VEGF, soluble VEGFR-1, VEGFR-2 and prognosis in breast cancer.
    Bando H; Weich HA; Brokelmann M; Horiguchi S; Funata N; Ogawa T; Toi M
    Br J Cancer; 2005 Feb; 92(3):553-61. PubMed ID: 15668703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia.
    Ahmad S; Ahmed A
    Circ Res; 2004 Oct; 95(9):884-91. PubMed ID: 15472115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor delays onset of failure in pressure-overload hypertrophy through matrix metalloproteinase activation and angiogenesis.
    Friehs I; Margossian RE; Moran AM; Cao-Danh H; Moses MA; del Nido PJ
    Basic Res Cardiol; 2006 May; 101(3):204-13. PubMed ID: 16369727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sunitinib inhibits inflammatory corneal lymphangiogenesis.
    Detry B; Blacher S; Erpicum C; Paupert J; Maertens L; Maillard C; Munaut C; Sounni NE; Lambert V; Foidart JM; Rakic JM; Cataldo D; Noël A
    Invest Ophthalmol Vis Sci; 2013 May; 54(5):3082-93. PubMed ID: 23580490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of colorectal cancer metastasis markers by an angiogenesis-related cytokine-antibody array.
    Abajo A; Bitarte N; Zarate R; Boni V; Lopez I; Gonzalez-Huarriz M; Rodriguez J; Bandres E; Garcia-Foncillas J
    World J Gastroenterol; 2012 Feb; 18(7):637-45. PubMed ID: 22363134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Placental growth factor, a member of the VEGF family, contributes to the development of choroidal neovascularization.
    Rakic JM; Lambert V; Devy L; Luttun A; Carmeliet P; Claes C; Nguyen L; Foidart JM; Noël A; Munaut C
    Invest Ophthalmol Vis Sci; 2003 Jul; 44(7):3186-93. PubMed ID: 12824270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of lymphangiogenesis by soluble vascular endothelial growth factor receptor-2 in a mouse lung cancer model.
    Maehana S; Nakamura M; Ogawa F; Imai R; Murakami R; Kojima F; Majima M; Kitasato H
    Biomed Pharmacother; 2016 Dec; 84():660-665. PubMed ID: 27697638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Placental expression of VEGF, PlGF and their receptors in a model of placental insufficiency-intrauterine growth restriction (PI-IUGR).
    Regnault TR; Orbus RJ; de Vrijer B; Davidsen ML; Galan HL; Wilkening RB; Anthony RV
    Placenta; 2002; 23(2-3):132-44. PubMed ID: 11945079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor (VEGF)-A165-induced prostacyclin synthesis requires the activation of VEGF receptor-1 and -2 heterodimer.
    Neagoe PE; Lemieux C; Sirois MG
    J Biol Chem; 2005 Mar; 280(11):9904-12. PubMed ID: 15637071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opposing roles for HIF-1α and HIF-2α in the regulation of angiogenesis by mononuclear phagocytes.
    Eubank TD; Roda JM; Liu H; O'Neil T; Marsh CB
    Blood; 2011 Jan; 117(1):323-32. PubMed ID: 20952691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VEGF-A induces its negative regulator, soluble form of VEGFR-1, by modulating its alternative splicing.
    Saito T; Takeda N; Amiya E; Nakao T; Abe H; Semba H; Soma K; Koyama K; Hosoya Y; Imai Y; Isagawa T; Watanabe M; Manabe I; Komuro I; Nagai R; Maemura K
    FEBS Lett; 2013 Jul; 587(14):2179-85. PubMed ID: 23711375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.